US Patent 7838015 Adjuvanted meningococcus compositions
Patent 7838015 was granted and assigned to Novartis on November, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+298 characters)
Article
Patent abstract
A combination of CpG oligonucleotides and polymer microparticles is an extremely effective adjuvant for Neisserial antigens. The invention therefore provides a composition comprising: (a) a Neisserial antigen; (b) a CpG oligonucleotide; and (c) a biodegradable polymer microparticle.
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07838015 Adjuvanted meningococcus compositions US Patent 7838015 Adjuvanted meningococcus compositions
Infobox
Patent Number
0783801500
Patent Number
783801500
Edits on 26 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
078380150
Date of Patent
November 23, 2010
0Patent Application Number
102648020
Date Filed
October 3, 2002
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
078380150
Date of Patent
November 23, 2010
0Patent Application Number
102648020
Date Filed
October 3, 2002
0Official Website
Patent Primary Examiner
Edits on 3 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 6 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07838015 Adjuvanted meningococcus compositions
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07838015
Date of patent
November 23, 2010
Patent application number
10264802
Date Filed
October 3, 2002
Patent primary examiner
Find more entities like US Patent 7838015 Adjuvanted meningococcus compositions
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.